YHP 2305
Alternative Names: YHP-2305Latest Information Update: 15 Oct 2024
At a glance
- Originator Yuhan
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 22 Aug 2024 Phase-I clinical trials in Unspecified in South Korea (PO) (NCT06613139),